Remdesivir is a novel antiviral drug in the class of nucleotide analogs. Remdesivir is a broad-spectrum antiviral medication. During the COVID‑19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in numerous countries. Remdesivir was originally developed to treat hepatitis C. Remdesivir was subsequently investigated for Ebola virus disease and Marburg virus infections, before being studied as a post- infection treatment for COVID‑19. Various Remdesivir related compounds or reference standards, listed on this page are needed in pharmaceutical research at the time to product development, ANDA filing or during production to study quality, stability, and genotoxicity study of Remdesivir related products.

Synthink is a most trusted source of Remdesivir Degradation Impurities, Remdesivir Genotoxic impurity, Remdesivir Process Impurities, USP related compounds, Remdesivir Nitrosamine impurity, N-Nitroso impurity etc. which are listed on this page.